Behaviorally Enhanced Messages to Increase Medical Check-ups(BEM-IMC)
NCT ID: NCT04324723
Last Updated: 2020-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
266 participants
INTERVENTIONAL
2018-11-07
2019-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a retrospective registration specifically focused on the RCT component of this study. The study was conducted by Nudge Lebanon in partnership with B4- development (formerly known as QBIU) and SmartScience. The RCT was not pre-registered because the collaborators were unaware that pre-registration would be necessary. The collaborators asked the University of Warwick to re-analyse and write the project up for publication after the study was complete. The University of Warwick is now seeking to retrospectively register the trial before submitting to an academic journal. The fact that this trial is retrospectively registered will be plainly stated in the manuscript and all analyses will be presented as exploratory.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Text Messages to Boost COVID-19 Vaccine Booking Rate
NCT05993260
Cardiovascular Health and Texting Messaging (CHAT) Study
NCT02888769
A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions
NCT04382521
The mCME Project:Delivering Continuing Medical Education for Community Health Workers Via SMS Text Messages
NCT02381743
Text-based Interventions to Promote COVID-19 Vaccinations
NCT04800965
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Stage 1. The opportunistic screening for hypertension was conducted around the 2018 Beirut Marathon. Screening tents were set up at the marathon village during the four days leading up to the marathon (7-10 November), where runners collected necessary materials for the run and could take up the screening. An additional two tents were set up during the marathon day were spectators could take part. Participants indicated their consent for the screening before taking part. During their participation they completed surveys about their demographics and health information (including whether they were hypertensive). After they completed the survey, nurses and trained team members measured their blood pressure using calibrated equipment. Those participants whose measurements indicated hypertension were invited to participate in the RCT.
Stage 2. For the RCT participants were randomly assigned to either a intervention or control group in a 1:1 fashion. Participants in the intervention group were sent a WhatsApp message 25 days after the marathon reminding them to seek help for their hypertensive condition. Participants in the control group were not sent this message. Then one month later the researchers called all these participants to ask wither they sought further medical attention. The main outcome was whether participants self-reported seeking further medical attention.
The research objectives were as follows:
Stage 1 screening: Evaluate if the opportunistic screening increased people's awareness of their hypertensive condition.
Stage 2 RCT: Evaluate if the intervention increased the proportion of participants who sought further medical attention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Participants in this group received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition.
WhatsApp message
The experimentally evaluated part of the intervention is a WhatsApp message.
The message translated from Arabic to English appears below. "Dear \[First name\], Your BP reading during Beirut Marathon was \[reading\]. This indicates that you have elevated blood pressure. You should seek medical attention at your earliest convenience. Your wellbeing matters to us. Nudge Lebanon team"
Control
Participants in this group did not received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WhatsApp message
The experimentally evaluated part of the intervention is a WhatsApp message.
The message translated from Arabic to English appears below. "Dear \[First name\], Your BP reading during Beirut Marathon was \[reading\]. This indicates that you have elevated blood pressure. You should seek medical attention at your earliest convenience. Your wellbeing matters to us. Nudge Lebanon team"
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* provided informed consented to participate in the trial, and
* provided valid contact details for a smart phone with WhatsApp messenger
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
B4Development Foundation (Supreme Committee for Delivery and Legacy)
UNKNOWN
Nudge Lebanon
UNKNOWN
University of Warwick
OTHER
Kelly Ann Schmidtke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kelly Ann Schmidtke
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fadi Makki, PhD
Role: PRINCIPAL_INVESTIGATOR
B4Development Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nudge Lebanon. 3rd Floor, GS Building, Sit Nasab Street
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.